Sort
51,593 grants matching “hepatitis”
Mechanistic function of HCV NS5A targeted by the potent inhibitors
$554,525Minkyung Yi · University Of Texas Med Br Galveston · R01 · FY2023 · AI
Understanding B cell memory in response to diverse virus infections
$554,521Michel C Nussenzweig · Rockefeller University · U19 · FY2019 · AI
Sustainable HIV Risk Reduction Strategies for CJ Systems
$554,460Wayne E.k. Lehman · Texas Christian University · R01 · FY2015 · DA
Immunopathogenesis of non-alcoholic fatty liver disease
$554,436Senad Divanovic · Cincinnati Childrens Hosp Med Ctr · R01 · FY2021 · DK
Immunopathogenesis of non-alcoholic fatty liver disease
$554,436Senad Divanovic · Cincinnati Childrens Hosp Med Ctr · R01 · FY2022 · DK
Immunopathogenesis of non-alcoholic fatty liver disease
$554,436Senad Divanovic · Cincinnati Childrens Hosp Med Ctr · R01 · FY2020 · DK
Immunopathogenesis of non-alcoholic fatty liver disease
$554,436Senad Divanovic · Cincinnati Childrens Hosp Med Ctr · R01 · FY2023 · DK
Impaired VLDL secretion in progression of NAFLD and NASH in mice and humans
$554,435Nicholas Davidson · Washington University · R01 · FY2025 · DK
Analysis of immunity, viral adaptation and pathogenesis in a new mouse model of HCV-related rodent hepacivirus infection
$554,390Charles M. Rice · Rockefeller University · R01 · FY2021 · AI
Genetic and Metabolic Basis of Familial Lipodystrophies
$554,390Abhimanyu Garg · Ut Southwestern Medical Center · R01 · FY2018 · DK
Genetic and Metabolic Basis of Familial Lipodystrophies
$554,390Abhimanyu Garg · Ut Southwestern Medical Center · R01 · FY2017 · DK
Broad Detection of Infectious Agents in Blood by Microarrays and Deep Sequencing
$554,384Charles Yen Chiu · University Of California, San Francisco · R01 · FY2013 · HL
Alcohol-induced hepatotoxicity - implications of secretin/secretin receptor axis
$554,365Gianfranco D. Alpini · Indiana University Indianapolis · R01 · FY2020 · AA
The H3Africa Kidney Disease Cohort Study
$554,337Akinlolu O Ojo · University Of Arizona · U01 · FY2017 · DK
Action Plans & Memory Consolidation: Reducing HIV Risk in Drug Users
$554,301Alan W Stacy · Claremont Graduate University · R01 · FY2013 · DA
PICORNAVIRUS MOLECULAR BIOLOGY
$554,262State University New York Stony Brook · R37 · FY2002 · AI
Funct character of GABA_B receptor modulators, drug metabolism, pharmacokinetics
$554,200Patrick Robert Griffin · University Of California, San Diego · U19 · FY2011 · DA
Mechanisms of hepatitis B virus cccDNA formation
$554,139Alexander Ploss · Princeton University · R01 · FY2021 · AI
Mechanisms of hepatitis B virus cccDNA formation
$554,139Alexander Ploss · Princeton University · R01 · FY2023 · AI
Mechanisms of hepatitis B virus cccDNA formation
$554,139Alexander Ploss · Princeton University · R01 · FY2024 · AI
Mechanisms of hepatitis B virus cccDNA formation
$554,139Alexander Ploss · Princeton University · R01 · FY2020 · AI
Mechanisms of hepatitis B virus cccDNA formation
$554,139Alexander Ploss · Princeton University · R01 · FY2022 · AI
Allosteric regulation of SIRT1 by a PACS-2 and DBC1 regulatory hub
$554,136Angela M. Gronenborn · University Of Pittsburgh At Pittsburgh · R01 · FY2017 · DK
Anti-HIV Microbicidal Peptides
$554,125Philippe Andre Gallay · Scripps Research Institute, The · R33 · FY2011 · AI
STING-Dependent Pathways Restraining Severe Schistosome Immunopathology
$554,016Parisa Kalantari · Tufts University Boston · R01 · FY2021 · AI